SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.
Phone: 02 9698 2022
Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)
Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...
Echelon Biosciences ionisable lipids
Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...
BioStatus CyTRAK Orange fluorescent dye
BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...